SPARCL1 and metabolic disease: To the best of our knowledge and based on the available literature, neither miRNA-6881-5P nor lncRNA lnc-SPARCL1-1:2 has been correlated with liver disease or other metabolic disorders to determine their actual implicating mechanisms.